SCHEMBL305057

SCHEMBL305057

CCCOCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18117386 0.94
SCHEMBL15160663 0.80
SCHEMBL8680867 0.78
Hydroxyl Radical SCHEMBL28108301 0.76
SCHEMBL23448 0.76
SCHEMBL28418615 0.76 HSD17B10 (0.47)
SCHEMBL14280626 0.76
SCHEMBL12811118 0.76
SCHEMBL56889 0.76
SCHEMBL23567252 0.76 THRB (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409480-A1 HALOALKYL ALKOXYMETHYL ETHER COMPOUND, AND PROCESS FOR PREPARING 4,6,8,10,16-PENTAMETHYLDOCOSANE THEREFROM AND FOR PREPARING SYNTHETIC INTERMEDIATE THEREFOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-12-12 US disclosed
US-20240400484-A1 HALOALKYL ALKOXYMETHYL ETHER COMPOUND, AND PROCESS FOR PREPARING 13,15-DIMETHYLHEPTACOSANE THEREFROM AND FOR PREPARING SYNTHETIC INTERMEDIATE THEREFOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-12-05 US disclosed
CN-119059888-A Haloalkyl oxymethyl ether compounds, process for preparing 13, 15-dimethylheptadecane therefrom and process for preparing synthetic intermediates thereof 信越化学工业株式会社 2024-12-03 CN disclosed
CN-119059889-A Haloalkylalkoxymethyl ether compound, process for producing 4,6,8,10,16-pentamethylbehene therefrom, and process for producing synthetic intermediate thereof 信越化学工业株式会社 2024-12-03 CN disclosed
CN-113024359-B Process for preparing alkoxymethyl alkynyl ether compounds having terminal triple bonds 信越化学工业株式会社 2024-06-11 CN disclosed
EP-3842406-B1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND SHINETSU CHEMICAL CO (JP) 2023-10-11 EP disclosed
US-11384041-B2 Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-07-12 US disclosed
US-20210198172-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-01 US disclosed
EP-3842406-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND Shin-Etsu Chemical Co., Ltd. (JP) 2021-06-30 EP disclosed
CN-113024359-A Method for producing alkoxymethyl alkynyl ether compounds having terminal triple bond 信越化学工业株式会社 2021-06-25 CN disclosed
EP-1840124-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE Otsuka Chemical Co., Ltd. (JP) 2007-10-03 EP disclosed
EP-1836163-A2 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN Novartis AG (CH) 2007-09-26 EP disclosed
EP-1837333-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE Otsuka Chemical Co., Ltd. (JP) 2007-09-26 EP disclosed
CN-1934082-A Organic compounds SPEEDEL EXPERIMENTA AG (CH) 2007-03-21 CN disclosed
US-20070037064-A1 contains N,N-diethyl-N-methyl-N-methoxymethylammonium Chloride OTSUKA CHEMICAL CO., LTD. (JP) 2007-02-15 US disclosed
US-20070004700-A1 2-Thioethenyl substituted carbapenem derivatives MEIJI SEIKA KAISHA, LTD. (JP) 2007-01-04 US disclosed
CN-1875517-A Electrolyte and non-aqueous electrolyte lithium secondary battery OTSUKA CHEMICAL CO LTD (JP) 2006-12-06 CN disclosed
WO-2006100036-A1 3, 4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION NOVARTIS AG (CH) 2006-09-28 WO disclosed
EP-1689016-A1 ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE LITHIUM SECONDARY BATTERY Stella Chemifa Corporation (JP) 2006-08-09 EP disclosed
WO-2006066896-A2 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN NOVARTIS AG (CH) 2006-06-29 WO disclosed